“瓣中瓣”技术在生物瓣膜衰败治疗上的应用  

Transcatheter Valve Implantation ‘Valve-in-valve’ Procedure for Surgical Degenerated Bioprosthesis

作　　者：姜海滨[1] 宗刚军[1] 

机构地区：[1]解放军第101医院心内科,江苏无锡214000

出　　处：《心血管病学进展》2013年第4期561-564,共4页Advances in Cardiovascular Diseases

摘　　要：生物瓣膜衰败是外科生物瓣膜置换后常见的远期并发症,再次行经胸外科手术换瓣手术难度大、风险高、病死率明显上升。经导管"瓣中瓣"技术是一种新型微创治疗外科生物瓣膜衰败的有效手段,现复习相关文献就该技术在生物瓣膜衰败治疗上新进展做一综述。Degenerative bioprosthesis is a common long-term complication after surgical valve implantation.Surgery to replace a degenerated valve is more difficult,with both a higher risk and mortality rate.The transcatheter valve implantation‘valve-in-valve’procedure is an effective minimally invasive treatment for a surgical degenerated bioprosthesis.This article summarizes progress in current research in transcatheter valve implantation‘valve-in-valve’procedure for surgical degenerated bioprosthesis.

关 键 词：瓣中瓣 生物瓣膜 经导管 

分 类 号：R654.2[医药卫生—外科学]